Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Tamir

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Virology|June 27, 2014
Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivoOlivia Perwitasari, Scott Johnson, Xiuzhen Yan, et al.
Scientific Reports|March 17, 2018
TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementiaHilary C Archbold, Kasey L Jackson, Ayush Arora, et al.
Ebiomedicine|October 27, 2015
Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related LymphomaEline Boons, Els Vanstreels, Maarten Jacquemyn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 25, 2022
Small Molecule Inhibitors of Nuclear Export and the Amelioration of Lupus by Modulation of Plasma Cell Generation and SurvivalJavier Rangel-Moreno, Maria de la Luz Garcia-Hernandez, Teresa Owen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2019
The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and MiceRylie M Hightower, Andrea L Reid, Devin E Gibbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2021
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent GlioblastomaAndrew B Lassman, Patrick Y Wen, Martin J van den Bent, et al.
Neuro-Oncology|April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experienceEudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Virology|June 27, 2014
Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivoOlivia Perwitasari, Scott Johnson, Xiuzhen Yan, et al.
Scientific Reports|March 17, 2018
TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementiaHilary C Archbold, Kasey L Jackson, Ayush Arora, et al.
Ebiomedicine|October 27, 2015
Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related LymphomaEline Boons, Els Vanstreels, Maarten Jacquemyn, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 25, 2022
Small Molecule Inhibitors of Nuclear Export and the Amelioration of Lupus by Modulation of Plasma Cell Generation and SurvivalJavier Rangel-Moreno, Maria de la Luz Garcia-Hernandez, Teresa Owen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2019
The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and MiceRylie M Hightower, Andrea L Reid, Devin E Gibbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2021
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent GlioblastomaAndrew B Lassman, Patrick Y Wen, Martin J van den Bent, et al.
Neuro-Oncology|April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experienceEudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Pageof 3